William P. Fay

7.0k total citations · 2 hit papers
93 papers, 5.5k citations indexed

About

William P. Fay is a scholar working on Hematology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, William P. Fay has authored 93 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 32 papers in Cancer Research and 22 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in William P. Fay's work include Blood Coagulation and Thrombosis Mechanisms (34 papers), Protease and Inhibitor Mechanisms (32 papers) and Blood properties and coagulation (11 papers). William P. Fay is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (34 papers), Protease and Inhibitor Mechanisms (32 papers) and Blood properties and coagulation (11 papers). William P. Fay collaborates with scholars based in United States, Canada and China. William P. Fay's co-authors include David Ginsburg, Yanhong Zhu, Amy D. Shapiro, Andrew C. Parker, Daniel T. Eitzman, Peter Carmeliet, Xianxian Zheng, Sharlene M. Day, Peter Farrehi and Tingliang Shen and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

William P. Fay

90 papers receiving 5.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.

1996 470 citations William P. Fay et al. Journal of Clinical Investigation profile →
Canadian Hemodialysis Morbidity Study

1992 449 citations David Churchill, D. Wayne Taylor et al. American Journal of Kidney Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William P. Fay United States	39	1.8k	1.3k	1.2k	1.1k	999	93	5.5k
Eduardo Anglés‐Cano France	36	1.1k 0.6×	1.4k 1.0×	1.1k 1.0×	618 0.6×	1.3k 1.3×	151	6.1k
Shosaku� Nomura Japan	46	2.4k 1.3×	503 0.4×	2.0k 1.7×	1.1k 1.0×	941 0.9×	310	6.5k
Perumal Thiagarajan United States	43	2.7k 1.5×	776 0.6×	2.9k 2.4×	789 0.7×	1.0k 1.0×	138	7.5k
Claudine Soria France	50	2.1k 1.2×	1.6k 1.2×	2.5k 2.1×	773 0.7×	1.8k 1.8×	212	7.8k
Laurent O. Mosnier United States	38	3.4k 1.9×	495 0.4×	821 0.7×	760 0.7×	541 0.5×	93	5.2k
Jan J. Sixma Netherlands	43	4.1k 2.3×	802 0.6×	2.0k 1.7×	1.2k 1.1×	1.2k 1.2×	155	7.7k
Beate E. Kehrel Germany	40	2.4k 1.3×	394 0.3×	1.5k 1.2×	1.4k 1.3×	883 0.9×	120	6.3k
Francisco España Spain	42	2.3k 1.3×	1.1k 0.8×	768 0.7×	819 0.8×	890 0.9×	177	5.2k
C. Arnold Spek Netherlands	41	1.5k 0.8×	485 0.4×	1.7k 1.4×	434 0.4×	651 0.7×	165	5.1k
Elliot S. Barnathan United States	42	1.3k 0.7×	873 0.7×	1.4k 1.2×	2.1k 1.9×	1.8k 1.8×	106	8.0k

Countries citing papers authored by William P. Fay

Since Specialization

Citations

This map shows the geographic impact of William P. Fay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William P. Fay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William P. Fay more than expected).

Fields of papers citing papers by William P. Fay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William P. Fay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William P. Fay. The network helps show where William P. Fay may publish in the future.

Co-authorship network of co-authors of William P. Fay

This figure shows the co-authorship network connecting the top 25 collaborators of William P. Fay. A scholar is included among the top collaborators of William P. Fay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William P. Fay. William P. Fay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ramirez‐Perez, Francisco I., Zhe Sun, Shumpei Fujie, et al.. (2024). PAI-1 Regulates the Cytoskeleton and Intrinsic Stiffness of Vascular Smooth Muscle Cells. Arteriosclerosis Thrombosis and Vascular Biology. 44(10). 2191–2203. 6 indexed citations

2.

Jones, John E., Meng Chen, Arun Kumar, et al.. (2023). In vitro biological responses of plasma nanocoatings for coronary stent applications. Journal of Biomedical Materials Research Part A. 111(11). 1768–1780. 3 indexed citations

3.

Ji, Yan, et al.. (2017). Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re‐endothelialization. Journal of Thrombosis and Haemostasis. 15(4). 814–825. 10 indexed citations

4.

Khoobchandani, Menka, et al.. (2016). Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis. International Journal of Molecular Sciences. 17(3). 316–316. 33 indexed citations

5.

Garg, Nadish & William P. Fay. (2007). Plasminogen Activator Inhibitor-1 and Restenosis. Current Drug Targets. 8(9). 1003–1006. 9 indexed citations

6.

Филиппов, С. И., Gerald Koenig, Tae‐Hwa Chun, et al.. (2005). MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. The Journal of Experimental Medicine. 202(5). 663–671. 106 indexed citations

7.

Day, Sharlene M., Damon Duquaine, Lakshmi Mundada, et al.. (2003). Chronic Iron Administration Increases Vascular Oxidative Stress and Accelerates Arterial Thrombosis. Circulation. 107(20). 2601–2606. 164 indexed citations

8.

Nagashima, Mariko, Lei Zhao, Kathy White, et al.. (2002). Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. Journal of Clinical Investigation. 109(1). 101–110. 116 indexed citations

9.

Nagashima, Mariko, Lei Zhao, Kathy White, et al.. (2002). Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. Journal of Clinical Investigation. 109(1). 101–110. 103 indexed citations

10.

Nagashima, Mariko, Lei Zhao, Kathy White, et al.. (2002). Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. Journal of Clinical Investigation. 109(1). 101–110. 4 indexed citations

11.

Sonnad, Seema S., et al.. (2002). Comparison of narrow versus standard target INR ranges. Journal of the American College of Cardiology. 39. 272–272. 5 indexed citations

12.

Zhu, Yanhong, et al.. (2002). Do clinically relevant circulating concentrations of radiographic contrast agents inhibit platelet-dependent arterial thrombosis?. Thrombosis Research. 105(5). 413–418. 6 indexed citations

13.

Mehta, Rajendra H., et al.. (2002). Prolonged low‐dose thrombolytic therapy: A novel adjunctive strategy in the management of an infected right atrial thrombus. Clinical Cardiology. 25(7). 346–349. 1 indexed citations

14.

Verhamme, Ingrid M., et al.. (2001). Streptokinase Triggers Conformational Activation of Plasminogen through Specific Interactions of the Amino-terminal Sequence and Stabilizes the Active Zymogen Conformation. Journal of Biological Chemistry. 276(28). 26084–26089. 38 indexed citations

15.

Borer, Katarina T., Jinbao Huang, Theodore J. Sanford, & William P. Fay. (2001). INCREASED PLASMA FIBRINOGEN AND DECREASED PLASMONOGEN ACTIVATOR INHIBITOR-1 (PAI-1) AFTER 15 WEEKS OF TRAINING IN POSTEMOPAUSAL WOMEN. Medicine & Science in Sports & Exercise. 33(5). S51–S51. 1 indexed citations

16.

Zhu, Yanhong, Peter Carmeliet, & William P. Fay. (1999). Plasminogen Activator Inhibitor-1 Is a Major Determinant of Arterial Thrombolysis Resistance. Circulation. 99(23). 3050–3055. 142 indexed citations

17.

Farrehi, Peter, C. Keith Ozaki, Peter Carmeliet, & William P. Fay. (1998). Regulation of Arterial Thrombolysis by Plasminogen Activator Inhibitor-1 in Mice. Circulation. 97(10). 1002–1008. 165 indexed citations

18.

Reis, Gilmar, et al.. (1995). Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. The American Journal of Cardiology. 75(10). 707–710. 87 indexed citations

19.

Churchill, David, D. Wayne Taylor, Richard J. Cook, et al.. (1992). Canadian Hemodialysis Morbidity Study. American Journal of Kidney Diseases. 19(3). 214–234. 449 indexed citations breakdown →

20.

Frommer, Peter L., Robert Uldall, William P. Fay, & G.A. Deveber. (1979). A case of acute interstitial nephritis successfully treated after delayed diagnosis.. PubMed. 121(5). 585–6, 591. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact